OK Biotech Co., Ltd. (TPE:4155)

OK Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	303.48	277.46	323.03	596.42	599.85	566.72
Trading Asset Securities	12.36	13.04	42.31	40.23	44.78	-
Cash & Short-Term Investments	315.84	290.5	365.34	636.64	644.64	566.72
Cash Growth	63.79%	-20.48%	-42.61%	-1.24%	13.75%	70.54%
Accounts Receivable	495.84	560.87	439.36	383.27	376.79	291.45
Other Receivables	30.84	27.62	49.23	26.21	28.11	14.69
Receivables	526.68	588.5	488.59	409.47	404.9	306.14
Inventory	485.62	530.54	394.05	422.95	375.64	349.07
Prepaid Expenses	59.98	62.35	64.47	49.47	57.76	53.33
Other Current Assets	1.48	0.79	4.91	7.98	6.06	0.31
Total Current Assets	1,390	1,473	1,317	1,527	1,489	1,276
Property, Plant & Equipment	1,918	1,627	865.71	874.73	659.4	606.04
Long-Term Investments	22.5	22.24	358.92	458.52	482.25	448.81
Goodwill	353.52	353.52	23.63	23.63	29.63	29.63
Other Intangible Assets	114.62	124.97	1.79	8.95	16.12	23.47
Long-Term Deferred Tax Assets	77.39	62.34	57.11	51.15	44.28	49.61
Other Long-Term Assets	17.36	32.39	442.84	117.71	92.09	101.92
Total Assets	3,893	3,695	3,067	3,061	2,813	2,535
Accounts Payable	185.87	258.32	203.8	244.63	240.4	207.56
Accrued Expenses	23.27	44.19	21.31	51.33	26.03	45.27
Short-Term Debt	460	305	155.03	185.73	187.04	172
Current Portion of Long-Term Debt	56.35	55.46	79.62	205.64	142.8	10.89
Current Portion of Leases	2.3	3.82	3.19	3.12	2.26	3.75
Current Income Taxes Payable	-	11.87	-	33.76	-	11.59
Current Unearned Revenue	21.43	48.44	90.32	67.83	53.87	40.15
Other Current Liabilities	25.58	17.67	24.86	36.14	48.16	162.2
Total Current Liabilities	774.8	744.76	578.13	828.18	700.55	653.42
Long-Term Debt	547.77	322	91.94	382.97	401.76	123.87
Long-Term Leases	18.89	33.77	2.17	3.17	-	3.8
Long-Term Deferred Tax Liabilities	27.32	27.85	-	0.43	-	-
Other Long-Term Liabilities	3.32	0.02	0.02	0.02	7.43	14.83
Total Liabilities	1,372	1,128	672.26	1,215	1,110	795.91
Common Stock	1,461	1,471	1,458	995.02	949.34	949.34
Additional Paid-In Capital	887.98	890.59	922.29	600.99	562.02	583.35
Retained Earnings	210.56	247.53	158.06	268.07	203.67	270.21
Treasury Stock	-11.8	-	-	-	-	-33.92
Comprehensive Income & Other	-88.51	-116.64	-140.19	-19.46	-10.52	-40.38
Total Common Equity	2,459	2,492	2,398	1,845	1,705	1,729
Minority Interest	62.41	74.84	-2.76	1.79	-1.5	10.54
Shareholders' Equity	2,521	2,567	2,395	1,846	1,703	1,739
Total Liabilities & Equity	3,893	3,695	3,067	3,061	2,813	2,535
Total Debt	1,085	720.05	331.95	780.63	733.86	314.31
Net Cash (Debt)	-769.47	-429.55	33.39	-143.98	-89.22	252.41
Net Cash Per Share	-5.34	-2.93	0.26	-1.11	-0.75	2.53
Filing Date Shares Outstanding	141.38	143.06	145.77	109.66	104.63	103.21
Total Common Shares Outstanding	141.38	143.06	145.77	109.66	104.63	103.21
Working Capital	614.8	727.9	739.22	698.33	788.44	622.15
Book Value Per Share	17.39	17.42	16.45	16.82	16.29	16.75
Tangible Book Value	1,991	2,014	2,372	1,812	1,659	1,675
Tangible Book Value Per Share	14.08	14.08	16.28	16.52	15.85	16.23
Land	417.61	417.61	417.61	417.61	185.4	185.4
Buildings	345.47	345.47	345.04	344.72	343.3	340.7
Machinery	343.44	321.15	320.7	286.11	190.59	142.44
Construction In Progress	1,106	791.9	20.51	16.01	93.21	60.4

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.